Ginkgo Bioworks Holdings, Inc. financial data

Symbol
DNA on NYSE, DNABW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
27 Drydock Avenue, 8 Th Floor, Boston, MA
Fiscal year end
December 31
Former names
Soaring Eagle Acquisition Corp. (to 9/17/2021), Spinning Eagle Acquisition Corp. (to 1/4/2021)
Latest financial report
10-Q - Q1 2025 - May 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 519 % -19.2%
Quick Ratio 0.44 % -90.5%
Return On Equity -65.4 % +50.5%
Return On Assets -42.5 % +57.3%
Operating Margin -198 % +49.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 54.7M shares -97.3%
Entity Public Float 617M USD -74.6%
Common Stock, Value, Issued 5K USD -97.5%
Weighted Average Number of Shares Outstanding, Basic 54.2M shares +8.24%
Weighted Average Number of Shares Outstanding, Diluted 54.2M shares +8.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 237M USD +13.8%
Research and Development Expense 359M USD -35.3%
General and Administrative Expense 225M USD -34.6%
Operating Income (Loss) -471M USD +43.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -472M USD +44.7%
Income Tax Expense (Benefit) -422K USD -246%
Net Income (Loss) Attributable to Parent -56.4M USD +81.4%
Earnings Per Share, Basic -8.91 USD/shares +58.7%
Earnings Per Share, Diluted -8.9 USD/shares +58.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 312M USD -62.8%
Marketable Securities, Current 12.8M USD
Accounts Receivable, after Allowance for Credit Loss, Current 26.3M USD +8.7%
Inventory, Net 46K USD -98.9%
Other Assets, Current 362K USD -25.7%
Assets, Current 565M USD -37.5%
Property, Plant and Equipment, Net 198M USD +0.94%
Operating Lease, Right-of-Use Asset 383M USD +73.7%
Intangible Assets, Net (Excluding Goodwill) 68.8M USD -11.2%
Goodwill 0 USD -100%
Other Assets, Noncurrent 46.8M USD -22.8%
Assets 1.29B USD -18.2%
Accounts Payable, Current 11.3M USD -58.3%
Employee-related Liabilities, Current 9.89M USD -36.9%
Contract with Customer, Liability, Current 33.7M USD +0.12%
Liabilities, Current 116M USD -31.6%
Contract with Customer, Liability, Noncurrent 80.4M USD -51.6%
Operating Lease, Liability, Noncurrent 435M USD +85.3%
Other Liabilities, Noncurrent 15.4M USD -38%
Liabilities 646M USD +8.67%
Accumulated Other Comprehensive Income (Loss), Net of Tax -850K USD +45.2%
Retained Earnings (Accumulated Deficit) -5.93B USD -8.65%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 647M USD -34.4%
Liabilities and Equity 1.29B USD -18.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -51.5M USD +42.3%
Net Cash Provided by (Used in) Financing Activities -207K USD +75.5%
Net Cash Provided by (Used in) Investing Activities -199M USD -1541%
Common Stock, Shares Authorized 15.8B shares 0%
Common Stock, Shares, Issued 58.1M shares -97.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -250M USD -145%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 355M USD -59.9%
Deferred Tax Assets, Valuation Allowance 772M USD +8.44%
Deferred Tax Assets, Gross 876M USD +13.4%
Operating Lease, Liability 467M USD +94.2%
Payments to Acquire Property, Plant, and Equipment 7.62M USD +13.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -471M USD +44.8%
Lessee, Operating Lease, Liability, to be Paid 724M USD +67.9%
Property, Plant and Equipment, Gross 361M USD +10.8%
Operating Lease, Liability, Current 28.6M USD +74.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 56.2M USD +24.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 61.2M USD +40.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 256M USD +34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 56.7M USD +43.9%
Deferred Tax Assets, Operating Loss Carryforwards 332M USD +19.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 58.4M USD +48.5%
Additional Paid in Capital 6.58B USD +2.04%
Amortization of Intangible Assets 19.3M USD +30.4%
Deferred Tax Assets, Net of Valuation Allowance 104M USD +72%
Share-based Payment Arrangement, Expense 92M USD -53.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%